Yagi & Co., Ltd.: New Material “LAVATECH” Containing Lava from Mt. Fuji to Be Exhibited at Heimtextil 2025
LAVATECH, which has a high far-infrared effect, to be unveiled for the first time at an international trade fair for home textiles and contract textiles
Yagi & Co., Ltd. (TOKYO:7460) (https://www.yaginet.co.jp/en/index.html) will unveil LAVATECH for the first time at the Heimtextil Exhibition in Germany (an international trade fair for home textiles and contract textiles). LAVATECH, which boasts a high far-infrared effect, is made by using special technology to finely crush lava rock found in the ground around Mt. Fuji for weaving into fibers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250110677601/en/
Mt. Fuji (Photo: Business Wire)
About LAVATECH
Since ancient times, the lava rock formed beneath Mt. Fuji has been carefully protected from changes in surface temperature and weathering. LAVATECH is made by weaving this high-quality underground lava rock. We have achieved a high far-infrared effect by using a special technology to finely crush the lava rock that lies underground at Mt. Fuji for weaving into fibers. This brand of materials enables the creation of new products that address a wide range of health issues in areas such as sleep, beauty and sports through their blood circulation-promoting effects.
LAVATECH official website: https://lavatech.jp/
Details of exhibit at Heimtextil 2025
At this exhibition, we will be displaying products in the fields of SLEEP, SPORTS, BEAUTY, and HEALTH that incorporate LAVATECH, this new material made using lava rock from Mt. Fuji.
Future developments
The Yagi Group's VISION is to unlock the potential of textiles through innovation to realize a sustainable society. We engage in various activities, with the key words of sustainable and global representing the basic strategies of our medium-term management plan. Through the development of LAVATECH, we will work to achieve the following.
- Develop new functional materials and expand global sales
- Improve awareness by strengthening branding and promotions through various sales channels
- Engage in the wellness business to support healthier lifestyle habits, which is directly linked to our Group’s ESG strategy
Overview of Heimtextil 2025
Heimtextil is the world's largest international trade fair for home and contract textiles, attracting over 2,800 exhibitors from all over the world. The trends disseminated from Heimtextil serve as guidelines for interior design, home furnishings, the hotel industry, and beyond.
Date and time: Tuesday, January 14 to Friday, January 17, 2025 9:00 a.m. to 6:00 p.m. (until 5:00 p.m. on the last day)
Venue: Frankfurt International Exhibition Center, Germany
Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany
Official website: https://heimtextil.messefrankfurt.com/frankfurt/en.html
*Advance registration and ticket purchase are required for entry.
Contact for inquiries regarding LAVATECH and exhibition details
Yagi & Co., Ltd.
Staff in charge: Wataru Yoshida, Section 241, Business Dept. 1, Lifestyle Division
MAIL: lavatech@yaginet.jp
TEL: +81-6-6266-7380
View source version on businesswire.com: https://www.businesswire.com/news/home/20250110677601/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore10.1.2025 13:30:00 CET | Press release
- Exclusive collaboration and licensing agreement for povetacicept in the region -- Zai Lab will leverage its local expertise and commercial footprint to accelerate development of povetacicept and bring the medicine to eligible patients in the region if approved - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the development and commercialization of Vertex’s povetacicept (pove) in mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore (the licensed territory). Pove is a recombinant fusion protein therapeutic and dual antagonist of BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) with best-in-class potential being studied for the treatment of Immunoglobulin A nephropathy (IgAN) and other B cell-mediated diseases. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250110
Compass Pathways Announces Pricing of Underwritten Offering10.1.2025 13:01:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten offering of 24,014,728 American Depositary Shares (“ADSs”) and in lieu of ADS, to certain institutional investors, pre-funded warrants to purchase up to 11,044,720 ADSs. Each ADS and pre-funded warrant shall be accompanied by a warrant (“ADS Warrant”) to purchase one ADS, which has an exercise price of $5.796 per ADS, representing a 40% premium to the last sale price and will be exercisable following a specified data milestone. The offering price is $4.275 per ADS and accompanying ADS Warrant, and $4.2649 per pre-funded warrant and accompanying ADS Warrant. All of the securities are to be sold by Compass. The offering is expected to close on or about January 13, 2025, subject to satisfaction of customary closing conditions. The offering was led by Deep Track Capital and included participation
Ronald S. Lauder to Retire from The Estée Lauder Companies’ Board of Directors10.1.2025 12:45:00 CET | Press release
Eric Zinterhofer to join the Company’s Board of Directors The Estée Lauder Companies (NYSE: EL) announced today that Ronald S. Lauder will retire from the Company’s Board of Directors (the “Board”) effective immediately. Pursuant to the stockholders’ agreement among Lauder family members and the Company, Mr. Lauder has the right to designate two directors of the Company. His daughter Jane Lauder will continue to serve on the Board in her current position, and he has named his son-in-law Eric Zinterhofer, who is married to his daughter Aerin Lauder, to be his second designee. In connection with Mr. Lauder’s retirement from the Board and his designation of Mr. Zinterhofer as his nominee, the Board has elected Mr. Zinterhofer effective immediately. Mr. Lauder will remain Chairman of Clinique Laboratories, LLC. Mr. Zinterhofer joins the Board with extensive financial, investing and global business experience, and is currently a Founding Partner of Searchlight Capital Partners. He serves on
GlobalLogic Announces Leadership Change: Srini Shankar Appointed as President and Chief Executive Officer10.1.2025 11:30:00 CET | Press release
GlobalLogic Inc., a Hitachi Group Company and leader in Digital Engineering, today announced that GlobalLogic’s Chief Business Officer (CBO) and Head of Global Industries, Srinivas (Srini) Shankar has been appointed its new President and CEO, effective February 3, 2025. Srini will succeed Nitesh Banga, who has decided to step down to pursue new opportunities outside of Hitachi and GlobalLogic. Nitesh joined GlobalLogic in June 2018. His leadership and expertise helped GlobalLogic achieve significant organic and inorganic growth, expand the organization’s offerings, capabilities, and footprint, and evolve as a global leader in Design-Led Digital Engineering. Nitesh also played a central role in GlobalLogic’s acquisition by Hitachi and has been paramount to the ongoing synergy success between GlobalLogic and Hitachi, including the expansion of GlobalLogic's business in Japan. “I am proud of the significant growth we achieved, the purposeful impact we’ve engineered for our clients and the
Ant Group Extends Partnership with Olympic Tennis Champion Qinwen Zheng as Brand Ambassador10.1.2025 07:57:00 CET | Press release
Ant Group today announced the extension of its successful partnership with Qinwen Zheng, the rising tennis legend and Olympic gold medalist. This renewed collaboration underscores the shared commitment to striving for excellence, while inspiring and engaging young people together. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250109266663/en/ (Photo: Business Wire) “I am excited to continue my partnership with Ant Group as a brand ambassador,” said Zheng. “Ant Group's unwavering commitment to inclusivity and equal development opportunities for diverse groups, particularly women and teenagers, aligns perfectly with my values. I look forward to our next chapter together to inspire even more young people to pursue their dreams.” In 2024, Zheng made history by winning the gold medal in women's singles at the Paris Olympics, becoming the first Asian tennis player to secure an Olympic singles title. Her perseverance, courage, and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom